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Transgenic mice expressing platelet-derived growth factor A chain (PDGF-A) in the distal lung epithelium from the
surfactant protein C (SPC) promoter were generated to investigate the role of this growth factor in lung development.
Expression of the SPC-PDGFA transgene resulted in an enlarged, nonfunctional lung and perinatal lethality caused by
failure to initiate ventilation. Histologic analysis of embryonic day (E) 16.5 lungs revealed increased mesenchymal cells and
acinar buds and decreased bronchioles and dilated airspaces in SPC-PDGFA transgenic mice. At E18.5, nontransgenic lungs
exhibited lung morphology typical of the saccular stage of lung development, including dilated airspaces, thin respiratory
epithelium and mesenchyme, and elastin fiber deposition in primary septa. In contrast, E18.5 transgenic lungs retained
many features of the canalicular stage of lung development, including undilated airspaces, cuboidal respiratory epithelium,
thickened mesenchyme, and lack of parenchymal elastin deposition. These results indicate that PDGF-A is a potent growth
factor for mesenchymal cells in the developing lung and that the downregulation of PDGF-A expression that normally
occurs in the lung during late gestation is required for transition from the canalicular to the saccular stage of lung
development. © 2001 Academic Pressw
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AINTRODUCTION
Mouse lung development begins with the formation of
the primitive lung buds around embryonic day (E) 9.5. The
system of conducting airways develops during the pseu-
doglandular period of lung development (E9.5–E16) by
branching of the primitive epithelial tubules under the
influence of the underlying mesenchyme. Demarcation of
distinct proximal and distal epithelium becomes apparent
at the end of the pseudoglandular period. In the subsequent
canalicular stage (E16.5–E17.5), the terminal acinar buds
form and begin to dilate. Further dilation of the terminal
buds and thinning of the epithelium and underlying mes-
enchyme occur in the saccular stage (E17.5–postnatal day
5), resulting in the development of the functional gas
exchange units. In the final stage of lung development,
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338hich occurs postnatally, secondary septa grow to subdi-
ide the saccules and form the alveoli found in the adult
ungs (Ten Have-Opbroek, 1991).
Reciprocal signaling between the pulmonary epithelium
nd mesenchyme is a critical component of developmental
echanisms in the embryonic lungs. Early evidence of this
henomenon was the induction of supernumerary budding
f tracheal epithelium when placed in contact with more
istal bronchial mesenchyme (Alescio and Cassini, 1962;
essells, 1970). Subsequently, it has been recognized that
oluble factors secreted by epithelial and mesenchymal
ells are important mediators of the reciprocal communi-
ation that occurs between these cell types during lung
evelopment.
Platelet-derived growth factor (PDGF) is expressed in the
eveloping lung and is likely to mediate interactions be-
ween the epithelium and mesenchyme. PDGF exists as
imers of A and B subunits that can form three isoforms:
A, AB, and BB (Hammacher et al., 1988; Heldin et al.,
986). PDGF receptors (PDGFR) also function as dimers of
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339Lung Development in PDGF-A Transgenic Micesubunits designated a and b. PDGF-BB can interact with all
three PDGFR dimers, whereas PDGF-AA can only bind to
PDGFR-aa (Hart et al., 1988; Seifert et al., 1989). PDGF is
a potent mitogen for mesenchymal cells, including lung
fibroblasts and airway smooth muscle cells (Buch et al.,
1994; Hirst et al., 1996; Osornio-Vargas et al., 1995).
PDGF-A is widely expressed in lung epithelium during the
pseudoglandular stage, but its expression declines until it is
not detected in late gestation (Bostrom et al., 1996; Lindahl
et al., 1997). PDGFR-a is expressed in mesenchymal cells
underlying the lung epithelium (Lindahl et al., 1997; Orr-
Urteger and Lonai, 1992). Studies in which PDGF-A expres-
sion is inhibited suggest an important role for this growth
factor in the regulation of lung morphogenesis. Inhibition of
PDGF-A or PDGF-B in embryonic lung explants using
antisense oligonucleotides reduced lung size, but only in-
hibition of PDGF-A expression reduced branching morpho-
genesis (Souza et al., 1994, 1995). In PDGF-A knockout
mice, no histologic abnormalities were reported before
birth, but postnatally the mice developed emphysema
caused by a defect in alveogenesis (Bostrom et al., 1996). To
further explore PDGF function in the embryonic lung, we
have generated transgenic mice in which expression of
PDGF-A was targeted to the distal epithelium under control
of the surfactant protein C (SPC) promoter. Here, we
describe that PDGF-A overexpression results in increased
lung mesenchyme and lung size, failure of airspace devel-
opment, and perinatal death. These results demonstrate
that PDGF-A is an important factor regulating the growth
of the lung and that the restriction of PDGF-A expression
that normally occurs in late gestation is important for the
development of the airspaces.
MATERIALS AND METHODS
Generation of Transgenic Mice
The human PDGF-A cDNA (clone 13.1), was kindly provided by
Christer Betsholtz (University Hospital, Uppsala, Sweden) (Rors-
man et al., 1988). A 1.1-kb EcoRI fragment containing the PDGF-A
FIG. 1. SPC-PDGFA DNA construct. The construct contains a
3.7-kb fragment from the human SPC promoter, a 1.1-kb human
fragment from the human PDGF-A cDNA, and a 0.5-kb fragment
from SV40 t-antigen containing intron and polyadenylation se-
quences. A 6.1-kb SacI fragment containing the SPC-PDGFA
construct was used for microinjection.DNA was inserted between the 3.7-kb human SPC promoter
Copyright © 2001 by Academic Press. All rightGlasser et al., 1991; Morris et al., 1998) and SV40 intron and
polyadenylation signals. The 6.1-kb SPC-PDGFA construct was
released by partial digestion with SacI and purified by agarose gel
electrophoresis. A 3-ng/ml solution of the linear construct was
microinjected into pronuclei of fertilized B6SJLF2 eggs (Brinster et
al., 1985). Mice that developed from injected eggs were allowed to
proceed to term or were obtained by Cesarean section on E16.5 or
E18.5. The day the copulation plug was observed was considered
E0.5. Embryos were genotyped by hybridization of DNA with a
radiolabeled human SPC probe.
Tissue Preparation
Cesarean section was performed after euthanasia of foster fe-
males on gestational days 16.5 and 18.5. Twelve hours before
collection of E16.5 embryos, each foster mother received an intra-
peritoneal injection of 40 mg/kg 59-bromodeoxyuridine (BrdU) in
PBS. E16.5 embryos were given a lethal injection of 2,2,2,-
tribromoethanol solution (Aldrich, Milwaukee, WI) and then fixed
by immersion in 10% buffered formalin overnight at 4°C. The
following day, samples were incubated in PBS two times for 30
min, and the lungs were removed. The samples were weighed,
embedded in paraffin, and sectioned at 5 mm. E18.5 embryos were
delivered and then placed on a 37°C warming plate. After 20 min of
observation, live embryos were administered a lethal injection of
tribromoethanol solution. Lungs of E18.5 embryos were fixed by
intratracheal infusion of 0.1 ml 10% buffered formalin solution and
then the body and inflated lungs were immersed in fixative
overnight at 4°C.
In Situ Hybridization
Lung sections were hybridized with a 0.5-kb probe derived from
SV40 sequences contained in the 39 untranslated region of the
SPC-PDGFA transgene message. The antisense and sense ribo-
probes were generated by in vitro transcription with T3 and T7
RNA polymerases, respectively (Promega, Madison, WI). Probes
were labeled by incorporation of digoxigenin-11-UTP (Boehringer
Mannheim, Indianapolis, IN).
In situ hybridization was performed as described (Liu et al.,
1998). In brief, sections were prehybridized with 50% formamide,
43 SSC at 37°C for 15 min, and then incubated with probe in
hybridization solution (40% formamide, 10% dextran sulfate, 13
Denhardt’s solution, 43 SSC, 10 mM DTT, 1 mg/ml yeast tRNA,
and 1 mg/ml sperm DNA) at 37°C for 4 h. After posthybridization
washes, sections were treated with 10 mg/ml RNase in 23 SSC
solution at 37°C for 30 min. Probe hybridization was detected by
using anti-digoxigenin-alkaline-phosphatase Fab fragments (Boeh-
ringer Mannheim) followed by staining with nitro blue tetrazolium/
TABLE 1
Generation of SPC-PDGFA Transgenic Mice
Age Litters
Transgenic embryos
(% of total embryos)
Total
embryos
E16.5 6 11 (23) 47
E18.5 4 4 (15) 26
Adult 10 0 (0) 64
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340 Li and Hoyle5-bromo-4-chloro-3-indolyl phosphate as described by the manu-
facturer (Boehringer Mannheim). No staining was observed when
sections from transgenic or nontransgenic mice were hybridized
with the sense riboprobe.
Antibodies and Immunohistochemistry
Goat serum against human PDGF-A (R&D Systems) was used at a
dilution of 1:100. Mouse monoclonal antibody against a-smooth
muscle actin (Dako, Carpinteria, CA) and mouse monoclonal anti-
body against desmin (Dako) were used at a dilution of 1:400. Rabbit
serum against surfactant protein B (SPB) (Dr. Jo Rae Wright, Duke
University, Durham, NC) was used at a dilution of 1:1000. Rabbit
serum against rat Clara cell secretory protein (CCSP) (Dr. Gurmukh
Singh, VA Medical Center, Pittsburgh, PA) was used at a dilution of
1:5000. Rat monoclonal anti-bromodeoxyuridine (BrdU) antibody (Ac-
curate, Westbury, NY) was used at a dilution of 1:50. Immunohisto-
chemistry for CCSP and SPB was performed by using an immunoper-
oxidase technique as previously described (Liu et al., 1997). For
FIG. 2. Gross appearance of lungs from SPC-PDGFA transgeni
nontransgenic (left) mice. (B) Ventral views of the same lungs (tran
of E18.5 lungs from transgenic (on right in each panel) and nontrans
lungs were inflated with 0.1 ml fixative. Arrowheads indicate the lo
enlarged lungs. Arrows indicate indentations caused by pressing oimmunohistochemistry with mouse monoclonal antibodies against
Copyright © 2001 by Academic Press. All rightdesmin and a-smooth muscle actin, a technique was used to inhibit
ackground caused by endogenous mouse IgG. Before inactivation of
ndogenous peroxidase by incubation in 3% hydrogen peroxide in
ethanol, sections were incubated in biotinylated goat anti-mouse
gG (Jackson ImmunoResearch, West Grove, PA) at 1:4000 at room
emperature for 30 min. After washing, sections were incubated with
nactivated horseradish peroxidase-conjugated streptavidin at 1:2000
500 ng/ml) at room temperature for 30 min. Subsequent steps were
erformed as described (Liu et al., 1997). For human PDGF-A immu-
ohistochemistry, sections were treated with 0.05% trypsin at room
emperature for 20 min prior to incubation with the primary antibody.
ound antibody was detected with peroxidase-conjugated donkey
nti-goat IgG followed by diaminobenzidine and hydrogen peroxide.
rdU immunohistochemistry was performed as described (Brass et al.,
999).
Morphometric Analysis
Samples for morphometric analysis were derived from three
ce. (A) Dorsal views of E16.5 lungs from transgenic (right) and
c on left, nontransgenic on right). (C) Dorsal and (D) ventral views
mice (on left in each panel). Note that in (C) and (D), the wild-type
n of the heart, which in the transgenic samples is obscured by the
lungs against the rib cage.c mi
sgeni
genic
catiolitters collected on the same day in which the lungs of all wild-type
s of reproduction in any form reserved.
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341Lung Development in PDGF-A Transgenic Miceembryos were of similar developmental stage. Lung sections (5 mm)
were stained with hematoxylin and eosin. To analyze bronchiole
numbers and airspace changes in the transgenic lungs, five to seven
FIG. 3. Lung weights in E16.5 SPC-PDGFA transgenic mice. (A)
Combined weight of lungs and heart. The weight of lungs and heart
mice in the four litters collected at E16.5 is shown. Each symbol
represents the measurement from one mouse. Fetuses in litter 4
appeared to be of a more advanced developmental stage than mice
in the other litters. The average weights for transgenic and non-
transgenic groups were calculated with and without the mice in
this litter. Average combined weights of lungs and heart were
(values excluding litter 4 in parentheses): transgenic mice 58.9 6
8.9 mg (52.5 6 7.5 mg) vs. nontransgenic mice 32.5 6 1.8 mg
29.8 6 1.0 mg), P 5 0.02 (P 5 0.03). (B) Weight of left lung.
verage weights of left lung were: transgenic mice 17.0 6 3.1 mg
15.8 6 3.1 mg) vs. nontransgenic mice 6.8 6 0.4 (6.2 6 0.2 mg), P 5
.01 (P 5 0.03).vertical sections per embryo at 40- to 50-mm intervals from the
Copyright © 2001 by Academic Press. All righthree heaviest E16.5 transgenic and nontransgenic left lungs were
tudied. Images were captured using a 43 objective and digitized
or analysis. The total number of bronchioles on each section was
ounted and the area of each section was measured by using NIH
mage software. To analyze the proportion of the sections occupied
y airways and airspaces, black-and-white images were made
inary and the interior white spaces of blood vessels were filled
anually. The “Analyze Particles” function of NIH Image was
hen used to measure section areas with or without the “Include
nterior Holes” option. The difference between the two measure-
ents is the area occupied by the lumens of airways and acinar
ubules. To analyze epithelial and mesenchymal compartments as
ell as the density of terminal buds in the peripheral lung, four
ung sections per mouse were photographed from five transgenic
nd five nontransgenic littermates in areas lacking large blood
essels and airways. For nontransgenic lungs, areas without dilated
irspaces in terminal buds were selected so they could be compared
o transgenic lungs in which pulmonary acini were undilated.
cini were outlined on the photographs with a black marker, and
cinar buds were counted. The photographs were then scanned and
nalyzed by using NIH Image. The area of the circled acini was
alculated, blood vessels and conducting bronchioles were erased
anually, and the remaining area was calculated as the mesenchy-
al area. To estimate the size of terminal respiratory units in
ransgenic and nontransgenic mice, the method of Emery and
ithal was used (Emery and Mithal, 1960). Photographs were taken
ith a 103 objective from three transgenic and three nontransgenic
ice. For each terminal bronchiole, a perpendicular line was drawn
rom the center of the respiratory tube to the nearest edge of the
ung. The number of acinar buds crossed by this line was counted
nd the length of the line was measured. Nine to ten such
easurements were made from each mouse.
Data Analysis
Data are presented as group means 6 SEM. Group means were
ompared using unpaired t tests except for BrdU labeling data, for
hich a paired t test was used. In the latter case, transgenic mice
ere paired with nontransgenic litter mates that were immediately
djacent in utero to compensate for developmental stage differ-
nces within and among litters.
RESULTS
Generation of SPC-PDGFA Transgenic Embryos
The SPC-PDGFA construct shown in Fig. 1 was microin-
jected into fertilized eggs to generate transgenic mice in
which PDGF-A expression was targeted to lung epithelium.
In initial experiments, microinjection of the SPC-PDGFA
construct failed to generate any mice carrying the transgene
at weaning (Table 1). This result suggested lethality at an
earlier stage. Thereafter, fetuses developing from microin-
jected eggs were obtained by Cesarean section at E16.5 and
E18.5, representing the canalicular and saccular stages of
mouse lung development, respectively. From these experi-
ments, 11 of 47 E16.5 fetuses and 4 of 26 E18.5 fetus were
identified as carrying the SPC-PDGFA transgene (Table 1).
s of reproduction in any form reserved.
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342 Li and HoyleSPC-PDGFA Mice Have Increased Lung Size and
Die Perinatally
The external appearance of transgenic mice was similar
to that of their normal littermates at E16.5 and E18.5. The
SPC-PDGFA transgene did not affect the viability of em-
bryos at E16.5. The external appearance and lung morphol-
ogy of one litter delivered at E16.5 appeared to be of a more
advanced developmental stage (ca. E17.5). Fetuses in this
litter were considered separately in some of the analyses as
noted below. The lungs and heart were removed en bloc
from E16.5 fetuses. Some lungs were observed to be abnor-
mally large. These lungs were photographed with lungs
from nearby littermates (Figs. 2A and 2B). Embryos with
these large lungs were later identified by DNA typing as
transgenic embryos. After the lungs and heart were
weighted en bloc, lung lobes were dissected for histologic
analysis and the left lobe was weighed. The average weight
of lungs and heart of 9 transgenic embryos from these 4
litters was 1.8 times that of the 27 wild-type littermates
(58.9 6 8.9 mg vs. 32.5 6 1.8 mg, P 5 0.02). The weight of
the left lobe of transgenic mice was 2.5 times that of the
normal left lobe (17.0 6 3.1 mg vs. 6.8 6 0.4 mg, P 5 0.01)
(Fig. 3).
Nontransgenic mice delivered by Cesarean section on
E18.5 initiated ventilation normally and turned pink within
a few minutes. In contrast, transgenic embryos (as revealed
by subsequent genotyping analysis) gasped a few times and
then died. Postmortem inspection revealed that the lungs of
transgenic mice did not collapse after dissection of thoracic
cage. Injecting any amount of fixative into the lungs of
transgenic mice was difficult, whereas the lungs of wild-
type littermates were easily inflated with 0.1 ml of fixative.
The lungs from transgenic embryos were larger than those
from wild-type embryos even after inflation of the latter
with fixative (Figs. 2C and 2D). Indentations from the ribs
and vertebral column indicated that the transgenic lungs
grew to press against the wall of the thoracic cage. These
findings showed that the SPC-PDGFA transgene resulted in
increased prenatal growth of the lung that interfered with
lung function. One transgenic embryo and one of its adja-
cent littermates died in utero. Histologic examination of
the lungs from the one dead transgenic embryo did not
reveal any abnormal pathology, which suggested that the
transgene was not expressed in the lung and that the mouse
died of unrelated causes.
Expression of the SPC-PDGFA Transgene
Expression of the PDGF-A transgene was analyzed by in
itu hybridization of lung sections with a probe derived
rom SV40 sequences in the 39 untranslated region of the
ransgene. As expected, no hybridization signal was de-
ected in nontransgenic lung (Fig. 4A). Transgene expres-
ion as evidenced by hybridization of the SV40 probe was
etected in epithelial cells in transgenic embryos on both
16.5 (Fig. 4B) and E18.5 (not shown). Transgene mRNA
as detected only in epithelial cells of terminal lung buds
Copyright © 2001 by Academic Press. All rightut not of bronchioles. The hybridization signal for the
ransgene was consistent with the known expression pat-
ern driven by the human SPC promoter in transgenic mice
Glasser et al., 1991; Wert et al., 1993). Expression of the
ransgene polypeptide was demonstrated by performing
mmunohistochemistry using antibodies against human
DGF-A. Staining was observed in SPC-PDGFA transgenic
ung at E16.5 (Fig. 4D) and E18.5 (not shown), but not in
ontransgenic lung (Fig. 4C). Staining for PDGF-A in trans-
enic lungs was observed in epithelial cells of terminal lung
uds, which was consistent with the location of mRNA
xpression found by in situ hybridization.
Lung Histology in SPC-PDGFA Transgenic Mice
Histologic analysis of E16.5 and E18.5 lungs revealed
distinct morphological changes in SPC-PDGFA transgenic
mice compared with their wild-type littermates (Fig. 5).
Transgenic mice (Fig. 5B) appeared to have reduced num-
bers of bronchioles compared with nontransgenic mice (Fig.
5A). This observation was confirmed by morphometric
analysis at E16.5, which revealed that transgenic mice had
only 18% of the number of bronchioles per unit area
compared with nontransgenic mice (Fig. 6A). In addition,
the percentage of the section area occupied by the lumens of
bronchioles and pulmonary acini was significantly reduced
in SPC-PDGFA transgenic mice (Fig. 6B). Transgenic lung
sections had an increased ratio of mesenchymal area to
acinar area, a result consistent with the action of PDGF on
mesenchymal cells (Fig. 6C). Transgenic lung sections had
slightly reduced numbers of acinar buds per unit area (Fig.
6D), but because transgenic lungs were over twice the size
of nontransgenic lungs, the total number of acinar buds was
larger in transgenic mice. An estimate of the size of the
terminal respiratory units in transgenic and nontransgenic
mice was made by measuring distances from the ends of
terminal bronchioles to the nearest edge of the section and
also counting the number of acinar buds within this dis-
tance (acinar bud index). Results of this analysis showed
that both these indicators were increased in SPC-PDGFA
transgenic lungs (Fig. 6E), suggesting an increased branch-
ing of the respiratory tubules. The organization of the
epithelium in E16.5 SPC-PDGFA lung appeared normal
(Fig. 5B, inset). In the litter with the developmental appear-
ance of E17.5, lungs from nontransgenic mice were in the
early saccular stage (not shown). The transgenic embryos in
this litter did not show any signs of progression to the
saccular stage (not shown).
Wild-type E18.5 fetuses exhibited normal histology for
the saccular stage of lung development, characterized by
dilated airspaces, flattened epithelium, and a thin mesen-
chymal cell layer between the airspaces (Figs. 5C and 5E).
SPC-PDGFA transgenic lungs lacked the normal saccular
appearance and retained many characteristics of the cana-
licular stage (Figs. 5D, 5F–5G). Transgenic lungs were
hypercellular and contained a thickened mesenchyme sur-
rounding the airspaces. The appearance of terminal tubules
s of reproduction in any form reserved.
m
o
o
a
g
t
P
g
r
l
w
p
c
a
343Lung Development in PDGF-A Transgenic Micevaried, with some being dilated and others undilated. The
dilated tubules were clustered (Fig. 5D, arrow) and pos-
sessed a characteristic morphology that differed from the
normal saccules in nontransgenic mice. The proportion of
dilated tubules varied among different lobes from the same
mouse and among different mice. In transgenic lungs,
undilated terminal tubules were lined by cuboidal epithe-
lial cells protruding into the airspaces with relatively clear
cytoplasm (Fig. 5G), whereas dilated terminal tubules were
lined with squamous and cuboidal epithelial cells (Fig. 5F).
Some sloughing of cuboidal epithelium was observed in
these dilated tubules. The most extensively dilated termi-
nal tubules were lined only with squamous epithelial cells.
The clustered distribution of dilated terminal buds suggests
an obstruction of the bronchioles to which these tubules
drain.
Effect of PDGF-A on Cell Proliferation
Because of the increased size of SPC-PDGFA lungs and
the known mitogenic properties of PDGF, cell proliferation
was examined by BrdU incorporation in lungs from E16.5
transgenic fetuses and their wild-type littermates. Pregnant
dams carrying SPC-PDGFA and nontransgenic embryos
were exposed to BrdU, and embryos were collected 12 h
later at E16.5. BrdU incorporation was analyzed by immu-
nohistochemistry, and labeled cells in the lung were
counted by light microscopy. A small but significant in-
crease in proliferative rate was observed in the transgenic
lungs (difference in BrdU-labeled cells between transgenic
and nontransgenic lungs 5 2.2 6 0.96%, P 5 0.03) (Fig. 7).
Epithelial Differentiation in SPC-PDGFA
Transgenic Lungs
To investigate whether epithelial differentiation was al-
tered in SPC-PDGFA transgenic lung, Clara cell secretory
protein (CCSP) and surfactant protein B (SPB) were detected
by immunohistochemistry (Fig. 8). CCSP is synthesized in
Clara cells, nonciliated epithelial cells of the airways. SPB
is expressed in the distal epithelium and bronchiolar epi-
thelial cells located in the airspaces and terminal bronchi-
oles. CCSP and SPB expression were not detected in E16.5
transgenic and nontransgenic lungs (not shown). However,
in the litter with the developmental appearance of E17.5,
CCSP was detected in nontransgenic embryos but not in
transgenic mice (Figs. 8A and 8B). At E18.5, CCSP immu-
nostaining appeared weaker in transgenic lungs than non-
transgenic lungs (Figs. 8C and 8D). These results indicate
that there is a delay in the differentiation of the airway
epithelium in SPC-PDGFA mice. Nontransgenic lungs at
E18.5 displayed the normal pattern of SPB staining in type
II alveolar epithelial cells of the saccules (Figs. 8E and 8G).
Lungs from SPC-PDGFA mice of the same age exhibited
more SPB-positive cells in lining the airspaces, and promi-
nent SPB-positive secretions were observed in the airways
and airspaces of transgenic mice (Figs. 8F, 8H, and 8I).
Copyright © 2001 by Academic Press. All rightMesenchymal Differentiation in SPC-PDGFA
Transgenic Lungs
Elastin fibers were detected in mesenchyme surrounding
airways and blood vessels but were absent in distal tubules
at E16.5 in both transgenic and nontransgenic lungs (not
shown). A network of fine elastin fibers occurred in the thin
mesenchyme of primary septa in nontransgenic lungs at
E18.5 (Fig. 8J). In the lungs of transgenic mice of this age,
normal elastin staining was observed around blood vessels
and airways, but the normal pattern of elastin fibers was not
present around the airspaces (Fig. 8K). No difference in
staining for a-smooth muscle actin (myofibroblast/smooth
uscle cell marker), desmin (smooth muscle cell marker),
r Von Willebrand’s factor (endothelial cell marker) was
bserved between transgenic and nontransgenic lungs.
DISCUSSION
In this study, overexpression of PDGF-A during lung
development resulted in increased lung growth, failure of
the airspaces to develop, and perinatal death caused by the
inability to initiate ventilation. This dramatic phenotype
indicates that PDGF-A is a potent growth factor in lung
development, and the results are in accordance with other
studies in which expression of PDGF-A was inhibited in the
developing lung. Treatment of lung organ cultures with
antisense PDGF-A oligonucleotides inhibited cellular pro-
liferation and resulted in smaller explants with reduced
branching and terminal buds (Souza et al., 1995). Our
results examining PDGF-A in the whole animal are consis-
tent with the concept that PDGF-A stimulates prenatal
lung growth and branching in terminal respiratory tubules.
Targeted inactivation of the PDGF-A gene in mice resulted
in death by 2–3 weeks postnatally from alveogenesis failure
(Bostrom et al., 1996). Lungs from PDGF-A knockout mice
ppeared normal before birth, suggesting that other mito-
ens may compensate for the lack of PDGF-A prenatally in
hese animals. Alternatively, the small fetus size in
DGF-A knockout mice may mask an inhibition of lung
rowth.
The appositional expression of PDGF-A and its cognate
eceptor during development suggests a paracrine stimu-
ation of PDGF-A on the adjacent mesenchymal cells. In
ild-type mice, PDGF-A is expressed throughout the
ulmonary epithelium on E14.5, but its expression de-
lines so that it cannot be detected by E18.5 (Bostrom et
l., 1996; Lindahl et al., 1997). The PDGF-a receptor is
widely expressed in mesenchymal cells underlying the
epithelium on E14.5 and subsequently becomes re-
stricted to a small number of cells in the saccular
mesenchyme. These cells are required for postnatal de-
velopment of alveoli, because secondary septal growth is
impaired in PDGF-A knockout mice that lack these cells
(Lindahl et al., 1997). In SPC-PDGFA transgenic mice,
widespread epithelial PDGF-A expression is maintained
in the latter stages of lung development and results in a
s of reproduction in any form reserved.
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344 Li and Hoylelung at E18.5 that retains many features of the canalicu-
lar stage, including undilated tubules with cuboidal epi-
thelium and a thick mesenchymal cell layer lacking
elastin fibers between the tubules. These results suggest
that downregulation of PDGF-A expression is an impor-
tant event in the transition from the canalicular to
saccular stage and that widespread PDGF-A expression in
the distal epithelium is incompatible with the dilation of
the airspaces and thinning of the underlying mesen-
chyme that normally occur during this time.
Interference with sacculation in SPC-PDGFA mice may
be a direct effect of mesenchymal cell proliferation produc-
FIG. 4. Transgene expression in the lungs of SPC-PDGFA mice. (A
o sequences in the 39 untranslated region of the SPC-PDGFA tran
mmunoperoxidase staining for human PDGF-A. (C) E16.5 nontraning thickened septa that prevent the formation of air sacs. t
Copyright © 2001 by Academic Press. All rightn addition, the altered physical environment in SPC-
DGFA lungs may interfere with formation of the air-
paces. Distention of the lung, as occurs during normal fetal
reathing movements or after tracheal ligation, stimulates
ilation of the airspaces and thinning of the distal epithe-
ium and mesenchyme (Carmel et al., 1965; De Paepe et al.,
998; Hooper et al., 1993). The abnormal growth of SPC-
DGFA lungs is likely to interfere with lung distention and
ay inhibit fetal breathing movements so that an essential
ignal generated by distention of the lung tissue is lacking.
SPC-PDGFA transgenic lungs had dramatically increased
ass on E16.5 and were clearly enlarged relative to non-
n situ hybridization with an antisense SV40 probe complementary
e. (A) E16.5 nontransgenic lung. (B) E16.5 transgenic lung. (C, D)
ic lung. (D) E16.5 transgenic lung. Bar, 25 mm., B) I
sgenransgenic lungs on E18.5. This increase in mass could
s of reproduction in any form reserved.
345Lung Development in PDGF-A Transgenic MiceFIG. 5. Lung histology. Histologic sections from SPC-PDGFA and wild-type lungs were stained with hematoxylin and eosin. (A) E16.5
nontransgenic lung. (B) E16.5 transgenic lung. (C) E18.5 nontransgenic lung. (D) E18.5 transgenic lung. Arrow indicates a cluster of dilated
respiratory tubules. (E) Higher magnification of the nontransgenic lung in (C). (F, G) Higher magnification of dilated (F) and undilated (G)
tubules from transgenic lung in (D). Bar in (C), 100 mm for (A–D); bar in inset of (A), 20 mm for insets in (A) and (B); bar in E, 20 mm for (E–G).
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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346 Li and Hoyleresult from an increase in cell proliferation and/or a de-
crease in apoptosis. Previous studies have shown that the
rate of apoptosis in the prenatal mouse lung is very low
(Bellusci et al., 1996), so that the large difference in size we
bserved is likely caused by increased proliferation in
ransgenic lungs. Lungs from SPC-PDGFA mice exhibited a
lightly higher percentage of BrdU-labeled cells at E16.5
ompared to wild-type littermates. Because transgenic
ungs were 2.5-fold larger than wild-type lungs at this time,
t is likely that larger differences in proliferation rates
FIG. 6. Morphometric measurements from E16.5 lung sections.
A) Bronchiole counts. (B) Percent of section area occupied by
irways and airspaces. (C) Ratio of mesenchymal to acinar area in
ung parenchyma. (D) Acinar bud counts in lung parenchyma. (E)
he size of terminal respiratory units was estimated by measuring
he distance from the end of a terminal bronchiole to the edge of
he section and counting the number of acinar buds crossed by this
ine (acinar bud index). These two indices are plotted with each
ymbol representing measurements from a single terminal respira-
ory unit. Average measurements 6 SEM were: distance from edge:
transgenic, 47.8 6 2.9 mm; nontransgenic, 14.3 6 1.3 mm, P ,
0.0001; acinar bud index: transgenic, 6.0 6 0.4; nontransgenic,
2.0 6 1.3; P , 0.0001.ccurred earlier in development. Proliferation in SPC-
Copyright © 2001 by Academic Press. All rightDGFA lungs during late gestation may be inhibited once
he lung grows to exert pressure on the thoracic cavity
ecause fetal breathing movements, which stimulate pro-
iferation in the lung, would be inhibited.
PDGF-A overexpression greatly increased fetal lung mes-
nchyme, as judged by the increase in fractional area of the
esenchyme and the overall increase in the size of the
ungs. This finding is consistent with the known prolifera-
ive effect of PDGF on mesenchymal cells. As in wild-type
ungs, cells in the mesenchymal layer surrounding epithe-
ial tubules did not express a-smooth muscle actin or
esmin. This result indicates that PDGF-A expression did
ot induce differentiation toward myofibroblast or smooth
uscle lineages in these cells. In contrast, overexpression
f TGF-b1 in the lung resulted in an increased mesenchy-
al cell compartment with alterations in the differentia-
ion of these cells (Zhou et al., 1996). A clear morphological
ifference in the mesenchyme of SPC-PDGFA mice at
18.5 was the lack of elastin fibers surrounding the epithe-
ial tubules, which contrasted with the normal density of
lastin fibers observed around larger airways and blood
essels. Impaired elastin deposition in mice overexpressing
DGF-A may appear to be incongruent with the phenotype
f PDGF-A knockout mice, in which elastin deposition
uring alveogenesis is also impaired (Bostrom et al., 1996).
hese differences can be reconciled by considering the
attern of tropoelastin expression, which proceeds in dis-
inct phases in the developing lung. Prenatally, tropoelastin
s expressed in mesenchymal cells underlying proximal
ubules at E15.5 and is widely expressed throughout lung
esenchyme at E18.5. Postnatally, tropoelastin is ex-
ressed in bronchial and vascular walls and in growing
eptal tips during alveogenesis (Lindahl et al., 1997).
DGF-A overexpression affects prenatal elastin deposition
n the lung parenchyma, whereas lack of PDGF-A affects
ostnatal elastin deposition during secondary septal forma-
ion.
Overexpression of PDGF-A had an inhibitory effect on
FIG. 7. BrdU incorporation in E16.5 lungs. Pregnant dams carry-
ing embryos from microinjected eggs were administered BrdU at
E16.0, and embryos were collected 12 h later at E16.5. Embryos
from litter 4 had the developmental appearance of E17.5. The
difference in the percentage of BrdU labeled cells between trans-
genic and nontransgenic mice was 2.2% 6 0.96%, P 5 0.03.
s of reproduction in any form reserved.
347Lung Development in PDGF-A Transgenic MiceFIG. 8. CCSP, SPB, and elastin staining. (A–D) Immunoperoxidase staining for CCSP protein. (A) Nontransgenic lung from the litter with
developmental appearance of E17.5. (B) Lung from transgenic littermate of mouse in (A). (C) E18.5 nontransgenic lung. (D) E18.5 transgenic
lung. (E–I) Immunoperoxidase staining for SPB protein. (E) E18.5 nontransgenic lung. (F) E18.5 transgenic lung. (G) Higher magnification of
the nontransgenic lung in (E). (H) Higher magnification of distal tubules in the transgenic lung in (F). (I) Higher magnification of bronchiole
in the transgenic lung in (F) showing SPB-positive secretions in the lumen. (J) Elastin staining in E18.5 nontransgenic lung. Arrows indicate
elastin fibers in the septal walls of the airspaces. (K) Elastin staining in E18.5 transgenic lung.
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348 Li and Hoylesome aspects of epithelial cell differentiation. Epithelial
tubules in E18.5 SPC-PDGFA lungs were lined with cuboi-
dal epithelia rather than the thin type-I cells in wild-type
saccules. SPB expression was readily detected in the distal
epithelium of transgenic mice starting at E18.5 as in wild-
type lungs. In contrast, the proximal epithelium appeared
normal structurally, but the expression of CCSP in the
airways was somewhat retarded in the transgenic mice.
Since PDGF-a receptor expression in the developing lung is
restricted to mesenchymal cells (Lindahl et al., 1997), the
ffects of PDGF-A on epithelial cells would appear to be
econdary to the mesenchymal cell growth and/or the
esultant physical changes in the lung. Effects on epithelial
ell growth and differentiation caused by perturbation of a
esenchymal cell growth factor underscore the intimate
nteractions between epithelial and mesenchymal cells
uring lung development.
In SPC-PDGFA transgenic lungs, the number of bronchi-
les decreased but the numbers of acinar buds increased,
uggesting an increase in distal branching in the transgenic
ice. In PDGF-A knockout mice, prenatal lung structure
ppeared normal, and deficiency of PDGF-A did not affect
he proximal–distal differentiation of epithelial cells. In
ontrast, other growth factors have been reported to regu-
ate the proximal–distal differentiation of lung epithelial
ells. Increased proximal cells and concurrently reduced
istal epithelial cells have been in reported in animal
odels with disruption of bone morphogenetic protein 4
ignaling or in fetal lung culture to which retinoid acid was
dded (Cardoso et al., 1995; Weaver et al., 1999). An
ncrease in the proportion of distal tubules and epithelial
ells, as occurs in SPC-PDGFA mice, has not been previ-
usly reported.
Manipulation of the expression of PDGF-A and PDGF-B
ubunits has demonstrated that these two molecules have
istinct functions in vivo. In PDGF-A knockout mice,
lveolar smooth muscle cell precursors expressing PDGF-a
receptors failed to develop, thereby interfering with alveo-
genesis. In PDGF-B knockout mice, pericytes expressing
PDGF-b receptors failed to develop, resulting in abnormal
apillary structure and hemorrhage (Leveen et al., 1994). In
hese cases, the differences in phenotype between PDGF-A
nd PDGF-B deficiency can be attributed to the expression
atterns of the growth factor ligands and receptors during
evelopment. We previously generated transgenic mice
verexpressing PDGF-B from the SPC promoter. These
ice survived to adulthood and developed lung disease
haracterized primarily by emphysematous lesions but also
y focal areas of fibrosis (Hoyle et al., 1999). Neonatal
PC-PDGFB mice exhibited increased airspace size and
hickened septa, but no abnormalities were observed before
irth. Since PDGF-B subunits can bind to both PDGF a and
b receptors but PDGF-A subunits can only bind to PDGF a
receptors, SPC-PDGFA mice would be expected to exhibit a
phenotype similar to or milder than SPC-PDGFB mice. The
observed effects of PDGF-A overexpression, i.e., increased
lung growth and perinatal lethality, did not occur in SPC-
Copyright © 2001 by Academic Press. All rightDGFB mice. Our observations are therefore somewhat
nexpected based on the known activities of PDGF iso-
orms in vitro. The results may be explained by differences
n intracellular signaling mediated by PDGF a and b recep-
tors as has been suggested (Rosenkranz and Kazlauskas,
1999) or by modulation of PDGF activity in vivo by binding
proteins such as a2-macroglobulin, which is known to
nhibit the activity of PDGF-B (Bonner and Brody, 1995;
onner et al., 1989). Further studies will be required to
lucidate the specific mechanisms by which overexpression
f the PDGF-A chain appears to promote a more severe lung
henotype than that of PDGF-B chain.
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